July 24, 2013 posted by

Why We Need To Take Fewer Drugs

Why We Need To Take Fewer Drugs

Americans take too many prescription drugs. Well all know that, right? I guess, given Big Pharma’s a hundred-billion-something dollar industry we don’t but trust me, our usage of prescription medications is way out of control. Unless you’re actually sick drugs won’t make you better. In fact, they generally make things worse. Medication should be situational; used sparingly when absolutely necessary. Instead, they compete on the market with staples like water and are commonly used prophylactically in an almost-always-misguided attempt to stave off problems before they happen.

Today’s anecdote, courtesy of Yahoo, is just another example of what’s wrong with the drug-shilling system of American health care.

Case #1

In June of 2012, the FDA approved the first prescription weight-loss drug in 13 years: lorcaserin, also known by its brand name, Belviq. The agency had denied the drug back in 2010 due to concerns over possible side effects (including heart problems), but after reviewing additional safety data decided the drug’s benefits outweighed the potential risks.

Less than a month later, the FDA approved a second weight-loss drug, Qsymia. Although there are some lingering safety concerns with Qsymia, too, these two drugs are expected to provide doctors a new way to fight the country’s stubborn obesity epidemic.

Yeah, yeah, I know what most of you are thinking: If it was really that dangerous that the FDA wouldn’t approve it. Not exactly.

Case #2

In July, pharmaceutical titan GlaxoSmithKline pleaded guilty to promoting drugs for unauthorized uses, agreeing in the process to pay an unprecedented $3 billion fine to settle the fraud charges.

The U.S. Department of Justice had accused the company of marketing the antidepressant Paxil to children and the antidepressant Wellbutrin for weight loss and sexual dysfunction, though the drugs are not approved for these indications. In addition, the government cited Glaxo for failing to report safety data on its blockbuster diabetes drug Avandia, which is no longer on the market.

“This historic action is a clear warning to any company that chooses to break the law,” Deputy Attorney General James Cole said at the time.

These companies are for profit, not health. They want you to buy shit, period. And it’s gotten to the point that they’re willing to shell out billions to stay in business when—oops–they kill a few people here and there. Whether it’s to lose weight, gain weight, sleep, wake up, feel happy, feel sad, not feel pain, whatever. Their MO is business, not health.

What these articles point out is that you might be able to lose weight by taking a pill but, even in the best-case scenarios, you’re going to have inevitable side effects that can be worse than being overweight. How can that be more popular than eating real food and moving your body around daily? Especially when the latter guarantees results, safely, 100% of the time. Have we really become this a) misinformed about how the human body works or b) lazy?

Yes, you might die from exercise but it’s really, really rare. And whenever you don’t die (99.999999% of the time) you get healthier. The worst side effects you’ll ever experience are muscle soreness and hunger pangs, which go away quickly.

I’m lucky because I see this process at work daily. I’ve lost count of how many people I’ve worked with who’ve dropped more than a hundred pounds. And, across the board, these cases systematically go off drugs as they getting fitter. They never add them. Unfortunately this is not the business model Big Pharma wants to promote and, since they have more money than us, it’s not what you’re going to hear.

the graphic on top looks almost identical to the obesity trend. coincidence? not likely. upside: it’s getting better. downside: we’ve a long long way to go. keep spreading the word. the grass roots health movement is having an effect.

Leave a Reply

Your email address will not be published.

* Copy This Password *

* Type Or Paste Password Here *